These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 12487927)
1. [Relationship between cyclooxygenase-2 protein expression, prostaglandins levels and biologic behavior in ovarian carcinoma tissue]. Tang L; Wang M; Ma J Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):687-90. PubMed ID: 12487927 [TBL] [Abstract][Full Text] [Related]
2. [Relation between COX-2 protein expression and biologic behavior of ovarian carcinoma]. Tang LX; Wang M; Ma JW Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):261-3. PubMed ID: 12839690 [TBL] [Abstract][Full Text] [Related]
3. [Experimental study of effects of cyclooxygenase-2 inhibitor on apoptosis of hypoxic myocardial cells in vitro]. Yin M; Shen H; Li TS; Li YP; Liu G Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):229-32. PubMed ID: 16647015 [TBL] [Abstract][Full Text] [Related]
4. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma. Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829 [TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas. Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191 [TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase 2 expression in serous tumors of the ovary. Singhal PK; Spiegel G; Driscoll D; Odunsi K; Lele S; Rodabaugh KJ Int J Gynecol Pathol; 2005 Jan; 24(1):62-6. PubMed ID: 15626918 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression in borderline ovarian tumors. Ferrandina G; Zannoni GF; Ranelletti FO; Legge F; Gessi M; Salutari V; Gallotta V; Lauriola L; Scambia G Gynecol Oncol; 2004 Oct; 95(1):46-51. PubMed ID: 15385109 [TBL] [Abstract][Full Text] [Related]
8. Involvement of inducible isoforms of COX and NOS in streptozotocin-pancreatic damage in the rat: interactions between nitridergic and prostanoid pathway. González E; Roselló-Catafau J; Jawerbaum A; Vela J; Sinner D; Pustovrh C; White V; Xaus C; Peralta C; Gimeno MA Prostaglandins Leukot Essent Fatty Acids; 2001 Jun; 64(6):311-6. PubMed ID: 11427040 [TBL] [Abstract][Full Text] [Related]
9. Quantitative characterization of prostaglandins in the uterus of early pregnant cattle. Ulbrich SE; Schulke K; Groebner AE; Reichenbach HD; Angioni C; Geisslinger G; Meyer HH Reproduction; 2009 Aug; 138(2):371-82. PubMed ID: 19470711 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Uefuji K; Ichikura T; Mochizuki H Clin Cancer Res; 2000 Jan; 6(1):135-8. PubMed ID: 10656441 [TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of vascular endothelial growth factor, cyclooxygenase-2, and Bcl-2 in borderline ovarian tumors. Li M; Qi SY; Wang Y; Feng SX; Zhang BZ; Wang R Arch Gynecol Obstet; 2005 Jun; 272(1):48-52. PubMed ID: 15682318 [TBL] [Abstract][Full Text] [Related]
12. Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo. Giuliano F; Mitchell JA; Warner TD J Pharmacol Exp Ther; 2001 Dec; 299(3):894-900. PubMed ID: 11714873 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
14. Selectivity of cyclooxygenase isoform activity and prostanoid production in normal and diseased Han:SPRD-cy rat kidneys. Warford-Woolgar L; Peng CY; Shuhyta J; Wakefield A; Sankaran D; Ogborn M; Aukema HM Am J Physiol Renal Physiol; 2006 Apr; 290(4):F897-904. PubMed ID: 16234308 [TBL] [Abstract][Full Text] [Related]
15. Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease. Peng CY; Sankaran D; Ogborn MR; Aukema HM Exp Biol Med (Maywood); 2009 Jul; 234(7):737-43. PubMed ID: 19429858 [TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas]. Wang HX; Chen QK Ai Zheng; 2003 Jun; 22(6):649-52. PubMed ID: 12948419 [TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Murata H; Kawano S; Tsuji S; Tsuji M; Sawaoka H; Kimura Y; Shiozaki H; Hori M Am J Gastroenterol; 1999 Feb; 94(2):451-5. PubMed ID: 10022645 [TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770 [TBL] [Abstract][Full Text] [Related]
19. [Expression of cyclooxygenase in bladder transitional cell carcinoma]. Wang KJ; Li H; Wei Q; Yang YR Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815 [TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]